Microbac   Report issue

For profit Phase 3 Phase 4
Founded: Pittsburgh PA United States (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
2016
NCT03326726
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Microbac | Microbac Laboratories, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: Microbac (0) Acquired (2)

chlorhexidine (hibitane) (8 trials)

isopropyl alcohol (5 trials)

Drugs in Phase 3 Trials (2)

Key: Microbac (0) Acquired (2)

iodine povacrylex (DuraPrep Surgical) (2 trials)

sodium chloride (3 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 8
  • # of Trial APIs: 4